Table 2.
Patients | Sex | Age | Clinical phenotype | BM volume (mL) (VB/IC) | BMM cells/mL of BM (107) (VB/IC) | Total stem cells at P1 (106) (VB/IC) | Culture period for P1 (days) (VB/IC) | Concentration of BMSCs (103/mL) (VB/IC) |
---|---|---|---|---|---|---|---|---|
1 | F | 75 | ASD | 4.0/4.0 | 4.5/5.6 | 1.28/0.70 | 10/13 | 2.50/0.34 |
2 | M | 52 | SS | 4.5/4.0 | 4.0/4.0 | 0.84/1.20 | 8/9 | 5.83/4.69 |
3 | M | 34 | SS | 4.8/4.8 | 8.4/9.2 | 1.00/0.90 | 8/9 | 6.51/2.93 |
4 | M | 31 | HNP recur | 5.0/5.5 | 6.8/7.6 | 1.56/1.34 | 8/8 | 9.75/7.61 |
5 | F | 40 | PTK | 4.0/5.4 | 5.6/4.4 | 1.00/1.12 | 7/8 | 7.81/6.48 |
6 | M | 38 | SS | 4.0/4.0 | 4.5/4.0 | 1.00/1.05 | 8/8 | 5.80/8.20 |
7 | M | 72 | SS | 4.0/4.0 | 3.0/2.5 | 0.50/0.60 | 9/12 | 1.95/0.59 |
8 | M | 47 | Bursting fracture | 4.0/4.0 | 3.6/2.8 | 0.90/0.90 | 9/8 | 3.51/7.03 |
9 | M | 66 | SS | 5.0/6.0 | 0.5/2.3 | 0.75/1.00 | 11/10 | 1.17/1.30 |
10 | F | 67 | SS | 4.3/3.3 | 1.0/1.0 | 0.32/0.50 | 11/11 | 0.58/1.18 |
11 | M | 66 | SS | 4.3/3.5 | 4.4/3.5 | 1.42/0.80 | 10/14 | 2.58/0.45 |
12 | M | 55 | SL | 3.5/5.5 | 0.4/1.5 | 0.01/0.56 | 11/10 | 0.02/0.80 |
13 | F | 64 | SS | 4.0/4.0 | 1.9/1.0 | 0.29/0.24 | 10/10 | 0.57/0.47 |
14 | M | 58 | SS | 4.0/7.0 | 2.5/6.2 | 0.47/0.58 | 8/8 | 3.67/2.59 |
BM bone marrow, BMM bone marrow mononuclear, BMSCs bone marrow stem cells, ASD adjacent segment degeneration, SS spinal stenosis, HNP herniated nucleus pulposus, PTK posttraumatic kyphosis, P1 passage 1